Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 74

Results For "scientific"

1210 News Found

BASF Pharma Solutions introduces premium services to its VPAs digital services platform
Digitisation | October 25, 2023

BASF Pharma Solutions introduces premium services to its VPAs digital services platform

Additional premium services in RegXcellence will include access to BASF’s Product Carbon Footprint data and direct downloads of audit reports


ERS Genomics completes licensing agreement with Syngene International
News | October 23, 2023

ERS Genomics completes licensing agreement with Syngene International

Syngene gains access to ERS Genomics' foundational CRISPR/Cas9 patent portfolio, ushering in a new era of technical innovation in India for its global partners


Sirio Pharma and Best Formulations announce US gummy manufacturing capabilities
News | October 16, 2023

Sirio Pharma and Best Formulations announce US gummy manufacturing capabilities

The new gummy capabilities include a dedicated R&D lab, an automated production line, and bottle packaging solutions


Shilpa Medicare launches 'Oraal’ for treatment of oral mucositis
News | October 13, 2023

Shilpa Medicare launches 'Oraal’ for treatment of oral mucositis

The composition of ORAAL is protected by a granted patent in India until November 2033


GlobalData predicts product cannibalization within electrophysiology ablation space
News | October 12, 2023

GlobalData predicts product cannibalization within electrophysiology ablation space

PFA technology is only marketed in Europe, and yet, it has been dominating the electrophysiology market by storm


Astellas, BioLabs and Mitsui Fudosan collaborate to enhance life science ecosystems in Tsukuba and Kashiwa-no-ha, Japan
News | October 11, 2023

Astellas, BioLabs and Mitsui Fudosan collaborate to enhance life science ecosystems in Tsukuba and Kashiwa-no-ha, Japan

Astellas stands on the forefront of healthcare change to turn innovative science into value for patients


Biocon Biologics gets complete response letter from USFDA for Biosimilar Insulin Aspart
Drug Approval | October 09, 2023

Biocon Biologics gets complete response letter from USFDA for Biosimilar Insulin Aspart

The company had submitted a comprehensive Corrective and Preventive Action (CAPA) plan in September 2022


Menarini strengthens its presence in aesthetic dermatology in India
News | September 30, 2023

Menarini strengthens its presence in aesthetic dermatology in India

The introduction of 'Definisse Core Filler' is a testament to the company's premium scientific-based innovation


Merck and Eisai update on Two Phase 3 Trials Evaluating Keytruda plus Lenima for cell lung cancer
Clinical Trials | September 23, 2023

Merck and Eisai update on Two Phase 3 Trials Evaluating Keytruda plus Lenima for cell lung cancer

The companies will work with investigators to share the results with the scientific community


Emmes appoints Peter Ronco as CEO
People | September 23, 2023

Emmes appoints Peter Ronco as CEO

Ronco succeeds Dr. Christine Dingivan, who will now serve as a senior advisor to Executive Chairman Sastry Chilukuri